The Ehlers-Danlos syndromes (EDS) comprise a clinically and genetically heterogeneous group of heritable connective tissue disorders (HCTDs), characterised by joint hypermobility, hyperextensibility of the skin and tissue fragility that can induce symptoms from multiple organ systems. The latest EDS nosology distinguished thirteen subtypes with an overlap of phenotypic features, making the clinical diagnosis rather difficult and highlighting the importance of molecular diagnostic confirmation.
Introduction
The term Ehlers-Danlos syndromes (EDS) refers to a heterogeneous group of heritable connective tissue disorders (HCTDs), mainly affecting skin, ligaments, joints and blood vessels. EDS is characterised by genetic heterogeneity and phenotypic variability: while the past Villefranche classification delineated six subtypes, most of which caused by mutations in genes encoding the collagen structure or biosynthesis [1] , recent advances in genetics led to a revised EDS classification in thirteen subtypes [2] , including defects in both non-collagenous extracellular matrix (ECM) proteins and intracellular processes.
Although the main features of EDS are generally recognised by specialists, emerging evidences define a wide spectrum of neurological manifestations that are unexpectedly common and potentially disabling: headache, fatigue, cerebrovascular disorders, chronic pain syndrome, peripheral neuropathy, plexopathy, spontaneous intracranial hypotension and epilepsy [3] . The severity of these manifestations ranges from very mild findings to severe debilitating illness [4] . Among the principal neurological features of EDS, epilepsy has been frequently described in literature, due mainly to structural anomalies often associated with periventricular heterotopia (PH) [5] , a group of neuronal migration disorders characterised by abnormal neuronal positioning that also includes bilateral nodular heterotopia (PNH). Concerning this association, it is important to note a particular case of an EDS 12-year-old girl with PH, which reported sudden headache as first symptom of presentation [6] .
Both generalized or focal seizures with various electroencephalography (EEG) features were found in these patients, associated with different kinds of epilepsy and specific brain malformations investigated by magnetic resonance imaging (MRI).
In this review, we report and analyze all cases of patients affected by EDS and epilepsy from both a clinical and genetic point of view.
Classification
The recent EDS nosology recognised thirteen subtypes based on clinical findings, inheritance pattern and molecular defects, as outlined in Table 1 [2] . All phenotypes show the basic clinical hallmarks of EDS, such as hypermobility, skin hyperextensibility and tissue fragility. The spectrum of joint hypermobility ranges from asymptomatic conditions to severe disabling symptoms. Given a great phenotypic and genetic EDS variability and the clinical overlap with the EDS subtypes or other HCTDs, a final diagnosis requires molecular confirmation with the identification of causative genetic variant, except for the hypermobile (hEDS), based on only clinical findings.
Both autosomal dominant and recessive inheritance patterns are found among different forms of EDS. These inheritance patterns are also common in other disorders that overlap clinical features with EDS. The genetic analysis can confirm or modify the clinical diagnosis and is thus essential for evaluating prognosis, making decisions on treatment and management strategies. Most of genes associated with EDS encode different types of collagen (COL1A1, COL1A2, COL1A3, COL5A1, COL5A2 and COL12A1) or proteins interacting with it or modifying enzymes (ADAMTS2, PLOD1, PRDM5, TNXB and ZNF469). Type-specific genetics, the involved proteins and their main functions are summarized in Table 1 .
The most common subtype of EDS is the hEDS, followed by the classical (cEDS) and the vascular (vEDS). The classification is very important for the management and counseling to the patients and their family. The subtypes are distinct from each other not only in their genetic causes, but also in their symptoms which can vary between individuals even in the same family.
EDS and epilepsy
Epilepsy was reported in people affected by EDS, especially in cases with structural brain abnormalities, such as PH or polymicrogyria. However, the mechanisms linking seizures to a hereditary defect of the connective tissue remain likely heterogeneous and poorly studied. A possible explanation of this association may be related to the fact that collagen plays an important role in neurological growth, migration, metabolism and differentiation [7] . A further evidence supporting this hypothesis is that seizures also occurred in three reported cases of patients affected by Stickler syndrome (STL), another connective tissue disorder [8] . Moreover, it has also been demonstrated the interaction between epidermal growth factor and the ECM is needed for the differentiation of cortical neurons [9] . So, a defect in collagen or in other ECM proteins in EDS patients may result in a structural failure of the cortical organization. The disruption in the link between the ECM and the cytoskeleton generates anomalies in cellular migration during development that can lead to malformations in vessels and brain parenchyma, contributing to seizures in EDS cases.
In the literature, patients affected by EDS syndrome and epilepsy have been frequently reported, as summarized in Table 2 . After the first case described by Herrero in 1972 [10] , some years later, Cupo et al. reported a 30-year-old woman with EDS and grand mal seizures who died of an intractable ventricular fibrillation due to myocardial infarction (aneurysms of the sinuses of Valsalva) [11] . She also presented cerebral heterotopias that probably generated the seizure disorder. Other authors described a similar case of EDS and myocardial infarction in a 24-year-old woman with complex partial and right sensory motor seizures associated to PH [12] .
Afterwards, in 1983 a 22-year-old female patient with EDS presented chronic focal seizures that began generalized, probably related to a congenital structural defect in the brain, as revealed by computed tomography (CT) [13] .
Jacome reported seven cases affected by EDS and epilepsy with seizures onset in the childhood. Among them, two were affected by occipital horn syndrome, which is not included in EDS spectrum anymore, and focal seizures associated to frontal gliosis and Dandy-Walker malformation occurring in the cerebellum. The remaining five individuals with more stringent diagnosis of EDS showed different brain complications that probably caused seizures, such as basilar artery hypoplasia, left hemispheric atrophy, venous parietal angioma, intracranial bleed and a previous stoke [14] . In 2000, for the first time, some authors described two EDS cases, showing bilateral polymicrogyria as a cause of epilepsy. The first patient was a 29-year-old male with focal seizures that evolved then into generalized and well controlled only by the adding of carbamazepine to the phenobarbital and valproate treatment. The second, a 22-year-old female, presented intractable seizures that were drug resistant [15] .
Among family studies, it is important to note an interesting case of a parental mosaicism: a point mutation p. Gly833Val in COL3A1 gene (coding the type III collagen) was detected not only in the family proband and in her mother, both affected by epileptic seizures, but unexpectedly also in the asymptomatic maternal grandmother, as a mosaic in somatic tissues [16] . Another family study was reported by Gòmez-Garre and collaborators in a Spanish family with three individuals affected by EDS, but only two of them had a history of seizures. The first, a 68-year-old woman, showed complex focal epilepsy followed by secondary tonic-clonic generalized seizures and the brain MRI revealed bilateral PNH. The second one, her 19-year-old grand-daughter, was affected by generalized epilepsy and had PNH associated with mega cisterna magna. Genetic analysis resulted in the identification of a novel missense mutation (p.Ala128Gly) in FLNA gene, encoding filamin A, an actin binding protein involved in cytoskeletal organization [17] . These most common clinical manifestations among patients, carrying FLNA mutations and affected by EDS and PH, led some authors to suggest a separate syndrome, termed as Ehlers-Danlos syndrome-periventricular heterotopia variant (EDS-PH) [17] [18] [19] . Nevertheless, the latest EDS nosology excluded this rare variant from the spectrum disorder. Previously, Sheen et al. also reported a case with similar clinical features due to the p. Ala39Gly FLNA mutation in a study in which seven EDS patients with seizures and PH were described, further suggesting the strong association between epilepsy and this cerebral malformation [19] .
Some authors described patients carrying mutations in genes encoding collagen, leading thus to an aberrant efficiency of protein secretion (Table 2) . Among them, only Savasta and collaborators identified a mutation in COL5A1 gene, which was detected in a 1-year-old female affected by afebrile generalized seizures and cEDS with a good response to valproate treatment. The brain MRI revealed unilateral PH, neurological condition associated for the first time with this clinical phenotype [20] . On the other hand, in the remaining cases, mutations occurred in COL3A1 gene. In particular, an already known splice-site variant (c. 1662 + 1 G > A) was identified in a vEDS 46-year-old woman presenting with generalized tonic-clonic seizures and cerebral infarction with micro-bleeds. This splicing mutation resulted in exon 24 skipping F. Cortini, C. Villa / Seizure 57 (2018) 1-4 [21] . Recently, Horn and collaborators described a case of two vEDS siblings carrying the missense mutation p.Pro49Ala in homozygous state. They both suffered from generalized epilepsy and the cerebral MRI showed bilateral frontoparietal polymicrogyria [22] . Their clinical data were in accordance with the findings in knockout mice in which the type III collagen seems to play a relevant role in cerebral cortical development in addition to its known contribution to the organization of ECM [23] . Interestingly, the same bi-allelic mutation was previously detected also in other two individuals who presented seizures, suggesting a link between epilepsy and defects in collagen production [24] . A similar case of those reported by Horn et al. was described in a 20-year-old male with familial history of vEDS, confirmed by genetic testing of COL3A1 gene. He also showed generalized seizures, probably generated by bilateral frontoparietal polymicrogyria, as revealed by brain MRI. The patient was resistant to valproate treatment, so the addition of clobazam was required [25] .
Another research group reported a vascular EDS case of a 4-year-old female presenting with focal convulsions, which was successfully managed with valproate and levetiracetam as anticonvulsant drugs [26] .
An important study that examined a series of 42 epileptic individuals affected by EDS was performed subdividing them according to the presence or absence of brain lesions, mainly PH. The large majority of the enrolled patients had the classical type of EDS, except three with the vascular form. After a long-term followup (at least five years), the outcome of epilepsy will be evaluated. Interestingly, the response to antiepileptic drug (AEDs) monotherapy was favorable in all individuals without brain lesions, whereas a worse outcome was observed in those with central nervous system (CNS) abnormalities, confirming that the epilepsy in the presence of cerebral structural anomalies is more frequent drug resistant [27] .
Conclusions
Epilepsy is an important cause of morbidity in EDS and should be taken in consideration for the care of these patients. The type, the severity and the age at onset of seizures are very variable. However, the pathological mechanisms leading to epilepsy are not clear: some authors hypothesised that the existence of brain lesions (e.g. PH or polymicrogyria) was considered the main cause [27] . Biochemical and genetic anomalies of the connective tissue probably underlie the pathogenesis of neurological manifestation of EDS. It would be interesting to understand if there is any possible correlation between different EDS subtypes and the various epileptic manifestations, but, unfortunately, the most of discussed cases showed the cEDS.
It is important to carefully evaluate patients showing asymptomatic or unrecognised anomalies to better define their prognosis. In this regard, MRI, EEG recording and neuropsychological tests may represent useful tools for defining diagnosis and caring for individuals affected by both EDS and epilepsy. Indeed, in most cases, the treatment with different AEDs in patients without brain abnormalities obtained good results. A better understanding of the mechanisms underneath the origin of seizures is useful to improve therapy and the out-come of these patients.
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